Cannell Capital’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-296,340
Closed -$7.2M 56
2020
Q1
$7.2M Sell
296,340
-35,387
-11% -$891K 3% 11
2019
Q4
$9.26M Sell
331,727
-55,561
-14% -$1.44M 3.01% 12
2019
Q3
$9.29M Sell
387,288
-59,018
-13% -$1.57M 3.02% 13
2019
Q2
$12.7M Sell
446,306
-821,319
-65% -$20.5M 3.61% 9
2019
Q1
$31.7M Sell
1,267,625
-428,761
-25% -$8.19M 7.71% 1
2018
Q4
$21.3M Sell
1,696,386
-63,351
-4% -$749K 5.96% 2
2018
Q3
$16.8M Sell
1,759,737
-652,607
-27% -$7.2M 4.47% 5
2018
Q2
$22.5M Buy
2,412,344
+353,111
+17% +$2.48M 5.78% 4
2018
Q1
$11.4M Buy
2,059,233
+146,606
+8% +$907K 3.68% 7
2017
Q4
$12.5M Buy
1,912,627
+249,220
+15% +$1.85M 3.63% 9
2017
Q3
$14.6M Hold
1,663,407
4.28% 7
2017
Q2
$13.9M Buy
1,663,407
+61,447
+4% +$501K 3.96% 8
2017
Q1
$14.7M Buy
1,601,960
+522,373
+48% +$4.27M 4.66% 7
2016
Q4
$8.36M Buy
1,079,587
+698,871
+184% +$5.23M 2.67% 12
2016
Q3
$2.9M Buy
+380,716
New +$2.15M 1.15% 30

Other funds holding VCYT

Cannell Capital's VCYT Position: Q2 2020 in Review

Cannell Capital sold out of Veracyte (VCYT) in Q2 2020, closing a stake of 296,340 shares — an estimated $7.2M sold.

Cannell Capital first reported a position in VCYT in Q3 2016 and held it in 15 quarters. The position peaked at $31.7M in Q1 2019. 166 funds tracked by Wall St. Rank hold VCYT as of Q2 2020.

  • Cannell Capital reported no remaining Veracyte position as of Q2 2020 after selling out during the quarter.
  • Cannell Capital sold 296,340 Veracyte shares in Q2 2020, an estimated $7.2M.
  • Cannell Capital first reported a position in Veracyte in Q3 2016 and held it in 15 quarters.
  • Cannell Capital's Veracyte position peaked at $31.7M in Q1 2019.
  • 166 funds tracked by Wall St. Rank held Veracyte as of Q2 2020.

Based on Cannell Capital's 13F filing for Q2 2020, filed 14 Aug 2020.